Kiadis Pharma

Sanofi shrinks $6B biobucks deal with IGM

Sanofi is shrinking a collaboration with IGM Biosciences by half, shedding three cancer targets to focus on three immunology and inflammation targets.

Gabrielle Masson Apr 17, 2024 11:05am

Forte taps new exec amid shareholder dissent—Chutes & Ladders

Jun 10, 2022 9:30am

Founder-led biotech makes space for ideas—and diverse leaders

Nov 23, 2021 7:00am

Ex-Kiadis CBO takes the helm at SynOx after $358M Sanofi buyout

Jul 27, 2021 11:14am

Sanofi inks $358M Kiadis takeover to acquire NK-cell platform

Nov 2, 2020 3:50am

Sanofi bags NK cells to boost effect of rival to J&J's Darzalex

Jul 8, 2020 8:20am